The Fort Worth Press - Avant Technologies and Ainnova in Talks to Obtain Innovative Technology in Preventative Health Reporting

USD -
AED 3.673042
AFN 65.000368
ALL 79.73251
AMD 363.440403
ANG 1.790365
AOA 918.000367
ARS 1514.501504
AUD 1.403499
AWG 1.8
AZN 1.70397
BAM 1.705151
BBD 2.014743
BDT 122.842733
BGN 1.683441
BHD 0.377072
BIF 3007.563373
BMD 1
BND 1.278286
BOB 9.828548
BRL 5.146304
BSD 1.000371
BTN 95.852241
BWP 13.566297
BYN 3.025994
BYR 19600
BZD 2.011918
CAD 1.39936
CDF 2311.000362
CHF 0.82201
CLF 0.024301
CLP 959.520396
CNY 6.70755
CNH 6.69545
COP 3187.61
CRC 447.525011
CUC 1
CUP 26.5
CVE 96.136744
CZK 21.21585
DJF 177.720393
DKK 6.51042
DOP 59.042263
DZD 133.780393
EGP 52.126904
ERN 15
ETB 163.400976
EUR 0.87093
FJD 2.215904
FKP 0.749304
GBP 0.746815
GEL 2.603861
GGP 0.749304
GHS 11.524327
GIP 0.749304
GMD 73.503851
GNF 8794.552556
GTQ 7.633994
GYD 209.29239
HKD 7.845635
HNL 26.85435
HRK 6.562704
HTG 130.743913
HUF 317.21604
IDR 17821
ILS 3.03663
IMP 0.749304
INR 95.92265
IQD 1310.490638
IRR 1374600.000352
ISK 121.230386
JEP 0.749304
JMD 157.960584
JOD 0.70904
JPY 156.694504
KES 129.503801
KGS 87.450384
KHR 4054.195438
KMF 428.00035
KPW 900.000318
KRW 1386.00035
KWD 0.30814
KYD 0.833682
KZT 447.238218
LAK 22425.000349
LBP 89550.000349
LKR 331.11734
LRD 173.066192
LSL 16.263563
LTL 2.95274
LVL 0.60489
LYD 6.354188
MAD 9.478186
MDL 17.581258
MGA 4336.662409
MKD 53.645926
MMK 2099.69268
MNT 3599.361607
MOP 8.083211
MRU 40.24412
MUR 47.570378
MVR 15.450378
MWK 1734.672526
MXN 17.23803
MYR 4.083804
MZN 63.910377
NAD 16.263705
NGN 1331.730377
NIO 36.809228
NOK 9.41007
NPR 153.367772
NZD 1.74738
OMR 0.3845
PAB 1.000379
PEN 3.37569
PGK 4.45264
PHP 62.892504
PKR 277.27411
PLN 3.798575
PYG 5930.433797
QAR 3.65652
RON 4.584038
RSD 102.234038
RUB 84.202551
RWF 1469.536863
SAR 3.726614
SBD 8.000512
SCR 14.051987
SDG 601.503676
SEK 9.834345
SGD 1.275885
SHP 0.747524
SLE 24.650371
SLL 20969.491881
SOS 571.677674
SRD 37.945504
STD 20697.981008
STN 21.360535
SVC 8.753575
SYP 13002.000254
SZL 16.258419
THB 33.310369
TJS 9.228308
TMT 3.51
TND 2.942646
TOP 2.40776
TRY 48.783104
TTD 6.790907
TWD 31.789504
TZS 2649.996038
UAH 44.694758
UGX 3945.963147
UYU 40.228081
UZS 11844.198871
VES 847.485104
VND 26022
VUV 118.29149
WST 2.754822
XAF 571.292904
XAG 0.014991
XAU 0.000228
XCD 2.70255
XCG 1.802885
XDR 0.707052
XOF 571.292904
XPF 103.976042
YER 236.550363
ZAR 16.25925
ZMK 9001.203584
ZMW 19.662326
ZWL 321.999592
SSP 5664.022588
MXV 1.954311
  • RBGPF

    -1.6900

    68.3

    -2.47%

  • CMSD

    0.0000

    20.45

    0%

  • CMSC

    0.0400

    20.71

    +0.19%

  • NGG

    -0.8000

    76.8

    -1.04%

  • GSK

    -0.8400

    50.22

    -1.67%

  • AZN

    -0.0600

    166.08

    -0.04%

  • RIO

    -0.6700

    97.37

    -0.69%

  • RYCEF

    0.7100

    20

    +3.55%

  • BTI

    -0.1900

    55.83

    -0.34%

  • RELX

    -0.9700

    33.41

    -2.9%

  • BCE

    -0.2200

    22.06

    -1%

  • BP

    -0.8400

    44.58

    -1.88%

  • JRI

    -0.0600

    11.55

    -0.52%

  • BCC

    0.1600

    75.69

    +0.21%

  • VOD

    -0.5700

    16.95

    -3.36%

Avant Technologies and Ainnova in Talks to Obtain Innovative Technology in Preventative Health Reporting
Avant Technologies and Ainnova in Talks to Obtain Innovative Technology in Preventative Health Reporting

Avant Technologies and Ainnova in Talks to Obtain Innovative Technology in Preventative Health Reporting

LAS VEGAS, NV / ACCESS Newswire / May 20, 2025 / Avant Technologies Inc. (OTCQB:AVAI) ("Avant" or the "Company"), and its JV partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence (AI), today announced the companies are in talks with an international healthcare innovation company to license or potentially acquire its patented early disease detection technology. If successful, it's a global license or acquisition that has the potential to revolutionize preventive health reporting and to generate correlations for future detection of new diseases without the need for all the patient's data.

Text size:

Avant and Ainnova continue to grow the footprint and capabilities of their technology portfolio with the goal of being a leader in early disease detection using the Company's signature AI-driven Vision AI technology platform.

Vinicio Vargas, Chief Executive Officer at Ainnova and member of the Board of Directors of the joint venture company, Ai-nova Acquisition Corp., said of the Company's aim to continue to add to its portfolio, "Our purpose is to create the future of early disease detection in an accessible way, so that patients can get a preventive check-up anywhere, at a low cost, and easily. We want to prevent patients with risk factors from developing other diseases that could have been avoided before they became a real problem.

"To this end, we are seeking to integrate new technologies into our portfolio within a single platform, both through our R&D efforts and through potential exclusive licenses or acquisitions."

Avant and Ainnova see the retina as a new vital sign, but also understand that leveraging the results of laboratory tests and basic patient data can all work in concert to provide a comprehensive health report.

Vargas added, "We have already integrated an exclusive license for four algorithms into our Vision AI platform, and we are now in talks to license and potentially acquire an innovative technology that would be a game changer in our industry."

Avant will inform its shareholders of any updates at an appropriate time.

About Ainnova Tech, Inc.

Ainnova is a Nevada-based healthtech startup with headquarters in San Jose, Costa Rica, and Houston, Texas. Founded by an experienced and innovative team that is dedicated to leveraging artificial intelligence for early disease detection. Recognized with multiple global awards and renowned partnerships with hospitals and medical device companies, we proudly introduce Vision AI - our cutting-edge platform designed to prevent blindness and detect the early onset of diabetes. Explore how Ainnova is revolutionizing healthcare through advanced technology and proactive solutions.

About Avant Technologies Inc.

Avant Technologies, Inc. is an emerging technology company developing solutions in artificial intelligence in healthcare. With a focus on pushing the boundaries of what is possible in AI and machine learning, Avant serves a diverse range of industries, driving progress and efficiency through state-of-the-art technology.

More information about Avant can be found at https://avanttechnologies.com

You can also follow us on social media at:

https://twitter.com/AvantTechAI

https://linkedin.com/company/avant-technologies-ai

https://www.facebook.com/AvantTechAI

https://www.youtube.com/@AvantTechAI

Forward-Looking Statements

Certain statements contained in this press release may constitute "forward-looking statements." Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements because of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company's ability to raise capital on acceptable terms, if at all, the Company's successful development of its products and the integration into its existing products and the commercial acceptance of the Company's products. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date after the date of the press release.

Contact:

Avant Technologies Inc.
[email protected]

SOURCE: Avant Technologies



View the original press release on ACCESS Newswire

C.Rojas--TFWP